AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

APREPITANT

10 registrations across 3 African markets— 9 active

Markets with APREPITANT

🇿🇦South Africa
8 registrations
8 active
🇹🇳Tunisia
1 registration
0 active
🇹🇿Tanzania
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
APEMEZE 80 mg🇿🇦South AfricaEurolab (Pty) LtdactiveNov 2028
APEMEZE 125 mg🇿🇦South AfricaEurolab (Pty) LtdactiveNov 2028
VOMEND 125🇿🇦South AfricaAdcock Ingram LimitedactiveJun 2028
PREPIX 125🇿🇦South AfricaAdcock Ingram LimitedactiveJun 2028
PREPIX 80🇿🇦South AfricaAdcock Ingram LimitedactiveJun 2028
VOMEND 80🇿🇦South AfricaAdcock Ingram LimitedactiveJun 2028
EMEND
Gélule / 80mg/125mg
🇹🇳TunisiaMerck Sharp & Dohme Ltd R.UexpiredApr 2020
EMEND 80🇿🇦South AfricaMSD (Pty) LtdactiveJan 1900
EMEND 125🇿🇦South AfricaMSD (Pty) LtdactiveJan 1900
APREPITANT 80 EUROLAB
Capsules, hard
🇹🇿TanzaniaEurolab (Pty) Ltdactive—

APREPITANT in Africa — Regulatory Overview

APREPITANT is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tunisia, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 9 (90%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.